ContentslistsavailableatScienceDirect
Journal
of
Virological
Methods
jou rn a l h om ep a ge :w w w . e l s e v i e r . c o m / l o c a t e / j v i r o m e t
Development
of
tailored
real-time
RT-PCR
assays
for
the
detection
and
differentiation
of
serotype
O,
A
and
Asia-1
foot-and-mouth
disease
virus
lineages
circulating
in
the
Middle
East
Scott
M.
Reid
a,1,
Valerie
Mioulet
a,
Nick
J.
Knowles
a,
Nazeem
Shirazi
b,
Graham
J.
Belsham
c,
Donald
P.
King
a,∗aPirbrightInstitute,AshRoad,Pirbright,Woking,SurreyGU240NF,UnitedKingdom bKhorasanRazaviCentralVeterinaryLaboratory,IranVeterinaryOrganization,Iran
cNationalVeterinaryInstitute,TechnicalUniversityofDenmark,Lindholm,4771Kalvehave,Denmark
Articlehistory: Received6April2014
Receivedinrevisedform26June2014 Accepted1July2014
Availableonline9July2014 Keywords:
Foot-and-mouthdiseasevirus FMDVserotyping
FMDVreal-timeserotypingRT-PCRassay FMDVmultiplexreal-timeserotyping RT-PCRassay
a
b
s
t
r
a
c
t
Rapidandaccuratediagnosisis essentialforeffectivecontroloffoot-and-mouthdisease(FMD).In
countrieswhereFMDisendemic,identificationoftheserotypesofthecausativevirusstrainsisimportant
forvaccineselectionandtracingthesourceofoutbreaks.Inthisstudy,real-timereversetranscription
polymerasechainreaction(rRT-PCR)assaysusingprimer/probesetsdesignedfromtheVP1codingregion
ofthevirusgenomesweredevelopedforthespecificdetectionofserotypeO,AandAsia-1FMDviruses
(FMDVs)circulatingintheMiddleEast.Theseassayswereevaluatedusingrepresentativefieldsamples
ofserotypeOstrainsbelongingexclusivelytothePanAsia-2lineage,serotypeAstrainsoftheIran-05
lin-eageandserotypeAsia-1virusesfromthreerelevantsub-groups.WhenRNAextractedfromarchivaland
contemporaryfieldstrainswastestedusingone-ortwo-steprRT-PCRassays,allthreeprimer/probesets
detectedtheRNAfromhomotypicvirusesandnocross-reactivitywasobservedwithheterotypicviruses.
Similarresultswereobtainedusingbothsingle-andmultiplexassayformats.Usingplasmidstandards,
theminimumdetectionlevelofthesetestswasfoundtobelowerthantwocopies.Theresultsillustrate
thepotentialoftailoredrRT-PCRtoolsforthedetectionandcategorizationofvirusescirculatinginthe
MiddleEastbelongingtodistinctsubgroupsofserotypesO,AandAsia-1.Theseassayscanalsoovercome
theproblemofserotypingsampleswhicharefoundpositivebythegenericrRT-PCRdiagnosticassaysbut
negativebyvirusisolationandantigen-detectionELISAwhichwouldotherwisehavetobeserotypedby
nucleotidesequencing.AsimilarapproachcouldbeusedtodevelopserotypingassaysforFMDVstrains
circulatinginotherregionsoftheworld.
©2014TheAuthors.PublishedbyElsevierB.V.ThisisanopenaccessarticleundertheCCBYlicense
(http://creativecommons.org/licenses/by/3.0/).
1. Introduction
Foot-and-mouthdisease(FMD)isahighlycontagiousvesicular diseaseofwildanddomesticcloven-hoofedanimals,particularly cattle,sheep,pigsandgoats.It isthemosteconomically impor-tantviraldiseaseofdomesticatedlivestockthroughouttheworld today,beingendemicinmanycountriesofAfrica,AsiaandSouth
∗ Correspondingauthor.Tel.:+4401483231131.
E-mailaddresses:[email protected],[email protected]
(D.P.King).
1 Presentaddress:DepartmentofAvianVirology,AnimalHealthandVeterinary
LaboratoriesAgency-Weybridge,WoodhamLane,NewHaw,Addlestone,Surrey KT153NB,UK.
America.However,outbreakscanalsooccurincountriesthatare normallyfreeofFMD:includingrecentlyJapanandKorea(2000 and2010),theUnitedKingdom(UK:2001and2007),Franceand TheNetherlands(2001)plusBulgaria(2010–2011).Thecausative agent,FMDvirus(FMDV),isasingle-strandedpositive-senseRNA virusofaround8.4kilobasesinlength,belongingtothegenus Aph-thoviruswithinthefamilyPicornaviridae(Belsham,2005).There aresevenimmunologicallydistinctserotypes:O,A,C,SAT (South-ernAfricanTerritories)1,SAT2,SAT3andAsia-1whichencompass adiverseantigenicspectrumofvirusstrains.Thesevenserotypes arenotdistributedequallyaroundtheworld(KnowlesandSamuel, 2003).SerotypesOandAarewidelydisseminatedbuttypeCviruses havenotbeendetectedsince2004,whileAsia-1,despitehaving beendetectedinGreece,ismainlyconfinedtotheAsiancontinent. http://dx.doi.org/10.1016/j.jviromet.2014.07.002
TheSATserotypesarenormally,butnotexclusively,restrictedto sub-SaharanAfrica.
IncountriesnormallyfreeofFMD,rapidconfirmationofFMDV asthecausativeagentinmaterialfromsuspectdiseasecasesis theprimarygoaloffieldandlaboratoryinvestigations.Anumber of generic (pan-serotypic)real-time reverse transcription poly-merasechainreaction(rRT-PCR)assayshave beendevelopedto targethighlyconservedregionsoftheRNAgenomeofFMDV(Reid et al., 2002; Callahan et al., 2002; Moniwa et al., 2007) which efficiently detect all sevenserotypes in clinicalsamples. These assays have undergoneextensiveevaluation;parallel testing of sampleshasshownthatthesensitivityofthesemolecularassays is atleast equal tothat ofthe current“gold standard”method ofvirusisolationincellculture(Shawetal.,2004; Ferrisetal., 2006;Kingetal.,2006;Reidetal.,2009).However,alimitationof therRT-PCRprocedurestargetingconservedsequencesin untrans-lated regions of the genome or those encoding non-structural proteinsisthattheycannotdeterminetheserotypeofthecausative FMDV.Therefore,usingtheseassaysitisnotpossibletoidentify theserotypeof virussamplesthat are positive byrRT-PCR but virusisolation (VI)/antigen-detectionELISA(Ag-ELISA)negative. Serotypingofthesesamplesmayonlybeaccomplishedbytheuseof serotype-specificprimersandprobesand/ornucleotide sequenc-ing.Serotype-specificprimer/probesetsmayalsobespecifically beneficialtothosecountriesthatcurrentlyuseonlythegeneric rRT-PCRassaysoracombinationofgenericrRT-PCRandAg-ELISA butnotVI.
In FMD-endemiccountries, identificationoftheserotypes of thecausativevirusstrainsisimportantforvaccineselection, dis-ease containment and for tracing thesource of theoutbreaks. ConventionalRT-PCRproceduresusingprimerscorrespondingto theVP1 (1D)codingregionandtothe2A/2B codingregionsfor serotyping of FMDV have beenreported (Vangrysperre and De Clercq,1996;CallensandDeClercq,1997).However,subsequent studies have shown that these agarose gel-based assays have relativelypoorsensitivityandspecificityduetothegenetic diver-sitywithinall FMDVserotypes (Reid etal., 1999,2001).While theseprocedurescanbeusedinconjunctionwithAg-ELISAand VItoprovideadditionalinformation,theyareinsufficiently sen-sitivetoreplacethemforprimarydiagnosisofFMD(Reidetal., 1999).AlternativeRT-PCRassaysreportedbySuryanarayanaetal. (1999)andAlexandersenetal.(2000)forserotype-specific diag-nosis were cumbersome and unsuitable for routine use in the eventofanepidemic.AconventionalRT-PCRprocedurefor dif-ferentiation of FMDV serotypes native to India using multiple primersbasedmostlyonnucleotidesequencesofviruses circulat-inginthatgeographicalareawasdescribed byGiridharanetal. (2005).These studiesdemonstrated the potentialfor using tai-loredmoleculartoolstoidentifyspecificserotypesasanalternative oradditiontopan-serotypicassaysfordetectionofFMDV.More recently,thedevelopmentand evaluationofareal-timereverse transcription-loop-mediated isothermal amplification assay for rapidserotypingofFMDVhasbeenreported(Madhanmohanetal., 2013).
Theobjective of this studywas todevelop tailoredrRT-PCR methods for identification of FMDV serotypes. In addition to usingthesetoolsinendemiccountries,suchanapproachwould overcome the problem of serotyping samples which are posi-tive by pan-serotypic rRT-PCR but cannot be sequenced using standardprotocols.ThiscollaborativestudybetweentheWRLFMD (ThePirbrirhgt Institute, UK), Technical University of Denmark (DTU) and Khorasan Razavi Central Veterinary Laboratory in Iran(CVL)describesthedevelopmentand evaluationoftailored serotype-specificrRT-PCRassaysforthedetectionofarchivaland contemporarystrainsofFMDVserotypesO,AandAsia-1circulating intheMiddleEast.
2. Materialsandmethods
2.1. Virusisolatesandsamplepreparation
FMDVisolateswereselectedfromarchivalstocksheldinthe WRLFMD(PirbrightInstitute, UK)repositoryat−20◦Cand
con-temporarysubmissionsfromwithintheserotypeOPanAsia-2and serotype A Iran-05 lineages, respectively, serotype Asia-1 sub-groups 1,2 and6, plusrepresentative FMDV-GenomeDetected samplesofundeterminedserotype(FMDV-GD:Ag-ELISAandVI negative). To check the diagnostic specificity of the serotype-specific primer/probe sets, archival and currently circulating serotype O and A viruses belonging to other topotypes (geo-graphicallyandgeneticallydistinctevolutionarylineages;Knowles and Samuel,2003)and serotypeAsia-1 virusesfromother sub-groupswerealsotested.Afurthercheckonthespecificityofthe primer/probesetswasmadebytestingFMDVstrainsbelongingto serotypesC,SAT1andSAT2plusrepresentativestrainsofswine vesiculardiseasevirus(SVDV)whicharecapableofcausing clini-callyindistinguishable(‘look-alike’)diseasetothatcausedbyFMDV inpigsandsomesamples,designated‘NVD’,fromwhichnovirus wasdetectedbyeitherAg-ELISA,VIorpan-serotypicrRT-PCR.Most samplescomprised∼10%(w/v)originalsuspensionsofvesicular epithelium(OS;FerrisandDawson,1988)whichhadbeentested byAg-ELISAandVI(FerrisandDawson,1988)atthetimeofreceipt. Additionalclinicalsamplessuchassalivasamplesorhomogenates generatedfromhearttissuewerealsotested,andcellculture super-natantsofselectedstrainsweretestedwhenOSwasunavailable.All thesamplestestedarelistedinthesupplementarydata—Annexes AandB.
2.2. Totalnucleicacidextraction
Total nucleic acid was extracted from the samples by an automated procedure (Shaw et al., 2007). Priorto nucleic acid extraction,0.2mlofOS,salivaorcellculture-grownviruseswere addedper0.3mlofLysis/BindingBuffer(Roche)or0.2mlofOSor cellculture-grownviruswasaddedto1.0mlofTRIzol®Reagent
(Invitrogen)andstoredat−70◦C.Nucleicacidextractionwasalso
performedmanuallyusingaQIAampViralRNAMiniKit(Qiagen) accordingtothemanufacturer’sinstructions.
2.3. Primerandprobedesign
GenBank sequences (http://www.ncbi.nlm.nih.gov/) were aligned from the VP1 coding region of the FMDV genome for serotypeOPanAsia-2,serotypeAIran-05andAsia-1strainsof sub-groups1,2and6,respectively,usingBioEdit(http://www.mbio. ncsu.edu/bioedit.html).Hydrolysis(TaqMan®)probesandprimers
were designed from conserved sequences using PrimerExpress version3.0software(AppliedBiosystems).
Inpilotexperiments,forserotypesOandA,twocandidate for-wardprimers,tworeverseprimersandoneprobeweredesigned for evaluation. Four forward primers, two reverse primers and fourprobeswereevaluatedinallcombinationsfordetectionof Asia-1 virus sequences of thethree targeted subgroups of this serotype.Thebest-performingprimer/probesetsforeachserotype were selected after all sets were tested by one-step rRT-PCR usinganamplificationprotocoladapted forroutinediagnosisof FMDV (Shaw et al.,2007)withtemplate nucleicacidextracted fromserotypeOPanAsia-2,serotypeAIran-05andAsia-1viruses (subgroups 1, 2 and 6, includingthe recently circulating Asia-1/Sindh-08lineage),respectively(datanotshown).Table1lists thesequencesofthebest-performingprimer/probesets.
Table1
FMDVserotype-specificityandsequenceoftheprimers/probesets.
Primer/probename Orientation FMDVserotypespecificity Sequence(5–3)
TypeOforprimer1 Forward Oa CCGAGACAGCGTTGGATAACA
TypeOrevprimer1 Reverse O CCATACTTGCAGTTCCCGTTGT
PanAsiaOprob349 Forward O FAM-CCGACTTGCACTGCCTTACACGGC-TAMRA
TypeAforprimer2 Forward Ab ACGACCATCCACGAGCTYC
TypeArevprimer2 Reverse A RCAGAGGCCTGGGACAGTAG
AIran05probe Forward A FAM-CGTGCGCATGAAACGTGCCG-TAMRA
Asia1forward3 Forward Asia-1c GCAGTWAAGGCYGAGASCATYAC
Asia1reverse2 Reverse Asia-1 GCARAGGCCTAGGGCAGTATG
Asia1probe4 Forward Asia-1 FAM-AGCTGTTGATCCGCATGAAACGYGCG-TAMRA
aFMDVserotypeOPanAsia-2lineage. b FMDVserotypeAIran-05lineage. c FMDVserotypeAsia-1subgroups1,2and6.
2.4. EvaluationoftheFMDVserotype-specificprimer/probesets inassaysonclinicalsamples
Clinical samples were tested at the WRLFMD (Pirbright Institute, UK) by one-step rRT-PCR assays using the serotype-specificprimer/probesetsruninparallelwiththegenericFMDV primer/probesetstargetingthe5 UTR(Reidetal.,2002)and3D codingregion(Callahanetal.,2002)usingtheprotocolofShaw etal. (2007). Thepan-serotypic assays,targeting independently conservedregionsoftheFMDVgenome,alsoservedtodetermine thepresence of FMDV RNA. AllrRT-PCR reactions wereset-up manuallyandamplificationsperformedinaStratageneMx3005P thermalcycler.
AtDTU(Lindholm,Denmark), two-steprRT-PCRassayswere performedwithrandomprimersforcDNApreparation followed byrRT-PCRamplificationtargetingthe5UTR(Reidetal.,2002), 3Dcoding region(Callahan etal., 2002)orusing the serotype-specificprimer/probesets.Fiftycyclesofreplicationwereusedin aStratageneMx3005Pthermalcycler.
TheCVL(Iran)methodologyusedbothone-andtwo-step rRT-PCRprotocolswiththebest-performingserotypeO,Aand Asia primers/probesetsfromTable1.AmplificationbyrRT-PCRwas performed in a Lightcycler 480 (Roche) or ABI 7500 (Applied Biosystems)thermalcyclerswiththefollowingamplification pro-gramme:anRTstepof50◦Cfor30min;denaturationat95◦Cfor 15min,1cycle;94◦Cfor30s,60◦Cfor1min,50cycles.
2.5. EvaluationofFMDVserotype-specificprimer/probesetsin multiplexassays
Theindividualserotype-specificassayswerecombinedtogether inamultiplexformatthatallowedsingleRNAsamplestobe simul-taneouslytested forallthreetargetswithinthesametube.The reactionsweresetupasamultiplexassaywiththeprobetargeting FMDVserotypeOlabelledwith5-Cy5and3-BlackHoleQuencher (BHQ)2,theprobetargetingFMDVserotypeAlabelledwith5 -FAMand3-BHQ1andtheprobetargetingFMDVserotypeAsia-1 labelledwith5-Cy3and3-BHQ2(Sigma-Aldrich,UK).Cycling con-ditionsusedintheseassayswereidenticaltothoseusedforthe individualassays. The diagnosticperformance of themultiplex
assaywascomparedtotheindividualcomponent(singleplex) rRT-PCRassays.
2.6. PreparationofRT-PCRproductssuitableasstandardsforthe serotype-specificrRT-PCRassays
RT reactions(in 20l) were set up containing 4l of RNA fromO/IRN/8/2005,A/IRN/1/2005andAsia1/IRN/10/2004using SuperScriptTMIIIreagents(Invitrogen,Paisley,UK)accordingtothe
manufacturer’sinstructionswith10Meachofthereverseprimers (Table2).Primers,RNA,wateranddNTPswerefirstcombinedand themixtureheatedto65◦Cfor5min,followedbychillingonice. Theremainingreagentsweresubsequentlyaddedandheatedat 50◦Cfor60minfollowedbya15mininactivationstepat95◦C.PCRs werepreparedusing a Platinum® Taqsystem(Invitrogen,
Pais-ley,UK)accordingtothemanufacturer’sinstructionswith10M eachoftheprimers(Table2).Amplificationresultedinthe produc-tionoffragmentsof231,168and197bpforserotypesO,Aand Asia-1,respectively,correspondingtotheassaytargetregion.The PCRcyclingprotocol(Bio-RadLaboratories,Herts,UK)included30 cyclesconsistingof30seachofdenaturationat94◦C,annealing at55◦Candextensionat68◦C.Oncompletionofcycling,an addi-tionalextensionstepof10minat68◦Cwascarriedoutfollowed byafinalholdstepat4◦C.ResultantPCRproductswerevisualised on2%(w/v)agarosegels(Sigma-Aldrich,UK),beforebeingexcised fromtheagarosegelandpurifiedusingaQiaquickGelExtractionKit (Qiagen,Crawley,UK)accordingtothemanufacturer’sinstructions. 2.7. Preparationofplasmidstandardsfordeterminationof
analyticalsensitivityofserotype-specificrRT-PCRassays
TheamplifiedassaytargetregionswereclonedintoapGEMT Easyvector(Promega,UK)accordingtothemanufacturer’s instruc-tions.Anumberofpositivecoloniesweregrownovernightin3mlof LB-brothcontaining50g/mlofampicillin.Plasmidswerepurified usingaQiagenplasmidminikit(Qiagen,Crawley,UK)according tothemanufacturer’sinstructionsandtestedforthepresenceof theassaytargetregionbyPCRwiththesameprimers.Thecorrect sequenceandorientationwasconfirmedbysequencingwithM13 forwardandreverseprimers(Promega,UK)ona3730DNA anal-yser(AppliedBiosystems,Warrington,UK)bydideoxy-sequencing
Table2
FMDVserotypespecificity,sequenceandampliconsizewiththeprimersetsusedtomakestandards.
Primername Sequence(5–3) FMDVserotypespecificity Size(bp)
SeroOquantfor TCGCAGACCTCGAGGTGG O(IRN8/2005) 231
SeroOquantrev CTTGCAGGTCACCTCTCACG O(IRN8/2005)
PEXSeroAquantfor GGGGTGACCTGGGGCCTCTTGCG A(IRN1/2005) 168
PEXSeroAquantrev TGTCCTGCGACAACACTTCCAC A(IRN1/2005)
PEXSeroAsia1quantfor GGAAACAACCTCACGGCGTGGTG Asia1(IRN10/2004) 197
usingaBigDye® Terminatorv3.1CycleSequencingKit(Applied
Biosystems)followingthemanufacturer’sinstructions.
RNAwastranscribedfrom0.4goflinearisedpGEMTplasmids
fromtheT7promotersiteusingaMEGAscript®T7invitro
transcrip-tionkit(Ambion,Warrington,UK)accordingtothemanufacturer’s
instructions except that transcription wascontinued overnight.
TranscribedRNAwasquantifiedusingaNanodrop(Thermo
Scien-tific,UK)andverifiedbyrunning1lRNAonaBioAnalyser(Agilent,
UK)usingtheRNA6000Nanokit(Agilent,UK).
2.8. Determinationofthedynamicrangeandanalytical
sensitivityoftheserotype-specificassaysusingtheRNAand
plasmidstandards
DilutionsoftheRNAtranscriptscontainingbetween1012and
100 copies/l wereusedastargetmaterialtotest thedynamic
rangeandsensitivityofthesingle-andmultiplexassays.Real-time
RT-PCRwascarriedoutusingSuperscriptIIIPlatinum®One-Step
qRT-PCRreactionmixand0.5lenzyme(Invitrogen,Paisley,UK).
The final reaction volume (25l) included 1.5l of probe at
5pmol/l;2lofeachprimerat10pmol/l,12.5l2×reaction
mix, 1.5l of DEPC-water (Ambion, Warrington, UK)per
reac-tionand5loftargetRNA.Real-timeRT-PCRreactions,including
standardRNAmaterialofbetween1012and100copies/l,were
carried out in quadruplicatein an Mx3005preal-time thermal
cycler(Stratagene,UK).Fortheseexperiments,thethermalcycling
conditionsincludedasingle60◦CcDNAsynthesisstepfor30min
followedbya95◦Cdenaturationstepof10minbeforePCRcycling
whichincluded50cyclesconsistingof15seachofdenaturation
at95◦C,andannealing/extensionat60◦Cfor1min(aspreviously
described;Shawetal.,2007).
3. Results
3.1. Diagnosticsensitivityandspecificityofserotype-specific rRT-PCRprimer/probeassaysinsingleplexandmultiplexassay formats
3.1.1. SingleplexrRT-PCRassayformat
RNA samplesderived from knownor suspect cases of FMD were assayed initially in singleplex rRT-PCR assays. Threshold cycle (CT)values wereassigned to each reaction as previously
described(Reidetal.,2002).Asforroutinediagnosisusingthe pan-serotypicone-steprRT-PCRassays,aCTvalueof32.0wasusedas
thepositive/negativecut-offpoint(Shawetal.,2007;Reidetal., 2009).Adefinitivepositive/negativecut-offwasnotassignedto theserotype-specificrRT-PCRassays;thestrongestresult(i.e. low-estCTvalue)generatedforeachsamplefromeithertheserotypeO,
AorAsia-1-specificprimer/probesetwasusedtodesignateanO, AorAsia-1serotypeforthatsample.
SingleplexassaydatageneratedfromWRLFMD,DTUandCVL are summarisedin Table2 and theresults fromtheindividual samplesarelistedinsupplementarydata—AnnexA.Assayswith thepan-serotypicprimersandprobesconfirmedthepresenceof FMDVRNAwithineachsample.Asexpected,bothpan-serotypic assays (targeting the 5 UTR and 3D coding regions) demon-stratedabroaderspectrumofreactivitythantheserotype-specific primer/probesetsanddetectedthegenomes ofserotypeC,SAT 1 and SAT 2 viruses, as wellas being broadlyreactive against serotypeO,AandAsia-1virusesacrossalltopotypes/lineages.All threeserotype-specificprimer/probesetstestedwerestrongly pos-itiveusingRNAextractedfromhomotypicserotypeO,AandAsia-1 virusesofthetargetedlineageorsubgroup.Therewereonlythree instances,allinvolvingtheserotypeO-specificprimers/probeset,
whenhomotypicvirusesofthenon-targetedlineage,weredetected (virusesbelongingtothetopotypesEA-3,EA-4andCATHAY).
Thespecificprimer/probesets weresuccessfulinidentifying fourofthe12FMDV-GDsamplestestedasserotypeOandsevenof thesesampleswereserotypeA.Ofthe12FMDV-GDsamplestested bythesingleplexformat,9and10samples,respectively,were pos-itivebythe5UTRand3Dpan-serotypicPCRassays,however,two samplestestingpositiveusingtheserotypeA-specificprimer/probe setwerenegativeinassayswithpan-serotypicprimer/probesets. No cross-reactivity was observed when the specific primer/probe sets were tested with heterotypic type O, A or Asia-1 isolates except when testing the serotype O PanAsia-2 sample O/PAK/4/2006which alsoproduced aweakreaction (of higher CT value)against the serotypeA-specific primers/probe
set.ThissamplemayhavebeenadualserotypeO/Ainfectionbut asa stronger CT value (28.33)wasproduced withtheserotype
O primer/probe set than that resulting from the heterologous serotype A set (CT value of 31.55), a serotype O identification
could be correctly deduced for this sample. Furthermore, no cross-reactivity was observed when all three serotype-specific primer/probe sets were tested against the heterologous FMDV serotypesC,SAT1andSAT2orwithSVDVisolates(Table3).
Atwo-stepsingleplexrRT-PCRformatwasalsousedatDTUand atCVLinparallelwiththeone-stepformat(datasummarisedin Table3).Liketheone-stepapproach,thetwo-stepassayswiththe specificprimer/probesetswerestronglyreactivewiththe target-tedtypeOstrainsofPanAsia-2lineage,typeAstrainsoftheIran-05 lineageandAsia-1virusesfromsubgroups1and2,respectively, butoverallassayperformancewasbetterwiththeone-step for-mat(datanotshown).Nocross-reactivitywasobservedwhenthe serotype-specificprimer/probesetsweretestedusingthetwo-step formatassaysagainsttheheterologousserotypeC,SAT1,SAT2and SAT3FMDVs.
3.1.2. MultiplexrRT-PCRassayformat
Thepositive/negativeacceptancecriteriaadoptedforthe pan-serotypicandserotype-specificrRT-PCRassaysusingthesingleplex formatweresimilarlyappliedforthemultiplexassaysperformed attheWRLFMD.MultiplexassaydataaresummarisedinTable3 and theCT valuesfromindividualsamplesarelistedin
supple-mentarydata—AnnexB.Specificityofdetectionusingtheserotype O,AandAsia-1primer/probesetsisalsoapparentfromtheheat maps(Fig.1a–c,respectively).Theseclearlydemonstratethestrong specificityofrecognitionoftheprimer/probesetsagainstthe tar-gettedvirussequencesoftheisolatesbelongingtotheserotype OPanAsia-2lineage(Fig.1a),serotypeAIran-05lineage(Fig.1b) andAsia-1subgroups1and2(Fig.1c),respectively.However,one sample(O/BAR/1/2008)didnotgenerateapositiveresultsforthe multiplexassayalthoughthesingleplexversionofthistestgavea positivesignal.
The samples Asia-1/PAK/32/2011 and Asia-1/PAK/109/2011 wereamongfiveAsia-1virusesintheAsia-1/Sindh-08lineagenot detectedbytheAsia-1-specificprimers/probesets.Bothviruses hadtwomismatchesintheprobe-bindingregionresultingin false-negativerRT-PCRresults.Table4showsthesequencesofselected Asia-1viruses,highlightingmismatchesintheprimerandprobe regions.AllotherAsia-1viruseslistedinTable4weredetectedby themultiplexassay.
Themultiplexassayformatwasalsosuccessfulinassigningthe serotypicidentity tosamplesdesignatedasFMDV-GD(Table3, supplementarydata—AnnexBandheatmap;Fig.1d).Eighty-five FMDV-GDsamplesweretested(77and82hadtestedpositiveby the 5 UTRand 3D assays, respectively) and of these, serotype O identity wasassigned to 33 samples,17 were designatedas serotypeAandfoursamplesweredesignatedasserotypeAsia-1.
Table3
SummaryoftherRT-PCRresultsusingserotypeO-,A-andAsia-1-specificandpan-serotypic5UTRand3Dprimers/probesetsinmultiplexandsingleplexassayformats.
FMDVserotype orother vesicularvirus FMDV topotypea FMDV lineageb
Ratioofnumberofsamplespositivetototal numbertestedbyrRT-PCRc
Ratioofnumberofsamplespositivetototal numbertestedbyrRT-PCRc
Multiplexassayformatd Singleplexassayformate,f
Og Ah Asia-1i 5UTR 3D Og Ah Asia-1i 5UTR 3D
O ME-SA PanAsia-2 12/13 0/13 0/13 13/13 13/13 26/26e5/5f 1/26e0/5f 0/26e0.5f 23/26e5/5f 24/26e5/5f
ME-SA PanAsia-2ANT-10 19/19 0/19 0/19 18/19 19/19 17/18e 0/18f 0/18f NTj 18/18f
ME-SA PanAsia-2FAR-09 2/2 0/2 0/2 2/2 2/2 NT NT NT NT NT
ME-SA PanAsia 5/5 0/5 0/5 5/5 5/5 NT NT NT NT NT ME-SA Unnamed 1/1 0/1 0/1 1/1 1/1 NT NT NT NT NT ME-SA Ind-2001d 1/1 0/1 0/1 1/1 1/1 NT NT NT NT NT SEA Unnamed 0/2 0/2 0/2 2/2 2/2 0/1e 0/1e 0/1e 1/1e 1/1e SEA Mya-98 1/10 0/10 0/10 10/10 10/10 NT NT NT NT NT EA-1 Unnamed 0/1 0/1 0/1 1/1 1/1 0/1e 0/1e 0/1e 1/1e 1/1e EA-2 Unnamed 0/2 0/2 0/2 2/2 2/2 0/2e 0/2e 0/2e 2/2e 2/2e EA-3 Unnamed 0/1 0/1 0/1 1/1 1/1 1/2e 0/2e 0/2e 2/2e 2/2e EA-4 Unnamed 0/1 0/1 0/1 1/1 1/1 1/1e 0/1e 0/1e 1/1e 1/1e WA Unnamed 0/1 0/1 0/1 1/1 1/1 0/1e 0/1e 0/1e 1/1e 1/1e ISA-1 Unnamed 0/1 0/1 0/1 1/1 1/1 0/1e 0/1e 0/1e 1/1e 1/1e ISA-2 Unnamed 0/1 0/1 0/1 1/1 1/1 0/1e 0/1e 0/1e 1/1e 1/1e CATHAY Unnamed 0/3 0/3 0/3 3/3 3/3 1/2e 0/2e 0/2e 2/2e 2/2e
A ASIA Iran-05AFG-07 0/16 16/16 0/16 15/16 16/16 NT NT NT NT NT
ASIA Iran-05FAR-09 0/1 1/1 0/1 1/1 1/1 NT NT NT NT NT
ASIA Iran-05BAR-08 0/4 4/4 0/4 4/4 4/4 NT NT NT NT NT
ASIA Iran-05 0/17 17/17 0/17 17/17 17/17 0/22e0/9f 22/22e8/9f 0/22e0/9f 22/22e5/9f 22/22e8/9f
ASIA Iran-05EZM-07 0/1 1/1 0/1 1/1 1/1 NT NT NT NT NT
ASIA Iran-05QAZ-11 0/2 2/2 0/2 2/2 2/2 NT NT NT NT NT
ASIA Iran-05ESF-10 0/1 1/1 0/1 1/1 1/1 NT NT NT NT NT
ASIA Iran-87 0/1 0/1 0/1 1/1 1/1 0/1e 0/1e 0/1e 1/1e 1/1e ASIA Iran-96 NT NT NT NT NT 0/3e0/2f 0/3e0/2f 0/3e0/2f 2/3e2/2f 3/3e2/2f ASIA Sea-97 0/4 2/4 0/4 4/4 4/4 NT NT NT NT NT AFRICA G-VIII 0/2 1/2 0/2 2/2 2/2 0/2e 1/2e 0/2e 2/2e 2/2e EURO-SA A24 0/1 1/1 0/1 1/1 1/1 0/1e 1/1e 0/1e 1/1e 1/1e EURO-SA A12 0/1 1/1 0/1 1/1 1/1 0/1e 1/1e 0/1e 1/1e 1/1e AFRICA G-VII 0/2 1/2 0/2 2/2 2/2 0/2e 1/2e 0/2e 2/2e 2/2e AFRICA G-II 0/1 0/1 0/1 1/1 1/1 1/1e 0/1e 0/1e 1/1e 1/1e AFRICA G-VI 0/2 0/2 0/2 2/2 2/2 0/2e 0/2e 0/2e 2/2e 2/2e AFRICA G-V 0/1 1/1 0/1 1/1 1/1 0/1e 1/1e 0/1e 1/1e 1/1e AFRICA G-IV 0/1 0/1 0/1 1/1 1/1 NT NT NT NT NT
Asia-1 ASIA Unnamed 0/4 0/4 4/4 4/4 4/4 0/1e 0/1e 0/1e 1/1e 1/1e
ASIA Sindh-08 0/12 0/12 7/12 12/12 12/12 NT NT NT NT NT ASIA Group1 NT NT NT NT NT 0/4e0/1f 0/4e0/1f 4/4e1/1f 4/4e1/1f 4/4e1/1f ASIA Group2 0/2 0/2 2/2 2/2 2/2 0/6e0/6f 0/6e0/6f 6/6e6/6f 6/6e1/2f 6/6e6/6f ASIA Group4 NT NT NT NT NT 0/1e 0/1e 1/1e 1/1e 1/1e ASIA Group5 NT NT NT NT NT 0/1e 0/1e 1/1e 1/1e 1/1e ASIA Group6 NT NT NT NT NT 0/2e 0/2e 2/2e 2/2e 2/2e C NT NT NT NT NT 0/1e0/1f 0/1e0/1f 0/1e0/1f 1/1e1/1f 1/1e1/1f SAT1 0/3 0/3 0/3 2/3 3/3 0/4e0/1f 0/4e0/1f 0/4e0/1f 2/4e1/1f 4/4e1/1f SAT2 0/3 0/3 0/3 3/3 3/3 0/4e0/4f 0/4e0/4f 0/4e0/4f 4/4e1/1f 4/4e4/4f SAT3 NT NT NT NT NT 0/1f 0/1f 0/1f 1/1f 1/1f FMDV-GDk 33/85 17/85 4/85 77/85k 82/85k 4/12e 7/12e,m 0/12e 9/12e,m 10/12e,m SVDVn 0/3 0/3 0/3 0/3 0/3 0/3e 0/3e 0/3e 0/3e 0/3e NVDo 0/4 0/4 0/4 0/4 0/4 NT NT NT NT NT
aFMDVtopotypes:ME-SA,MiddleEast-SouthAsia;SEA,SouthEastAsia;EA-1,EA-2,EA-3andEA-4,EastAfrica1–4;WA,WestAfrica;ISA1,ISA-2,Indonesia1and2. b http://www.wrlfmd.org/fmdgenotyping/prototypes.htm.
c Forpan-serotypicrRT-PCRassays,samplesproducingaC
Tvalue<32.0wereconsideredpositive;withallserotype-specificrRT-PCRassays,thelowestCTvaluegenerated
amongsttheprimers/probesetsuseddefinedtheserotype.Resultsinboldtyperepresentapparentanomalousresultswherepositiveresultswereachievedbythespecific primer/probesetusingRNAextractedfromhomotypicserotypeO,AandAsia-1viruseshomotypicvirusesofthenon-targetedlineagelineageorsubgroup.
d AllmultiplexdataweregeneratedattheWRLFMD.
eSingleplexdatageneratedattheWRLFMDusingone-steprRT-PCRassays.
f SingleplexdatageneratedfromDTUandCVLusingeitherone-ortwo-steprRT-PCRassays. gPrimers/probeset:TypeOforprimer1/TypeOrevprimer1/PanAsiaOprob349.
h Primers/probeset:TypeAforprimer2/TypeArevprimer2/AIran05probe. i Primers/probeset:Asia1forward3/Asia1reverse2/Asia1probe4. j NT,nottested.
k FMDV-GD,FMDV-genomedetectedsamples,i.e.samplesofundeterminedserotypethatarepositivebyrRT-PCRbutVI/Ag-ELISA-negative. lThirty-sixsampleswereFMDV-genomedetected(byatleastonegenericprimers/probeset)butnegativeusingserotype-specificprimers/probesets.
m TwosampleswerepositiveusingTypeAforprimer2/TypeArevprimer2/AIran05probesetwerenegativeusingpan-serotypicprimer/probesets. n SVDV,swinevesiculardiseasevirus.
Fig.1.Diagnosticsensitivityandspecificityofthelineage-specificrRT-PCRassaysinmultiplexedformat(togetherwithcomparativedataforthepan-serotypicrRT-PCR assays)todetectrepresentativeFMDviruspositivesamplesfromserotypeOPanAsia-2lineage(a),serotypeAIran-05lineage(b)andAsia-1subgroups1and2(c).Dataare presentedasaheat-mapforCTvaluesgeneratedwiththedifferentrRT-PCRassays(scaleshown).Neighbor-joiningtreesshownrepresentgeneticrelationshipsbetween
VP1sequencesfortheindividualviruses.Individualdatavaluesarepresentedinsupplementaldata.
Table4
SequencesofserotypeAsia-1FMDV sampleshighlightingmismatches withprimers andprobesequences. SamplesAsia-1/PAK/32/2011and Asia-1/PAK/109/2011werenotdetectedbythemultiplexrRT-PCRassay.
21
Asia-1 FMDV sample Forward primer (5’ -3’) Probe (5’ –3’) Reverse primer 3’ -5’) GCAGTWAAGGCYGAGASCATYAC AGCTGTTGATCCGCATGAAACGYGCG CATACTGCCCTAGGCCTYTGC Asia-1/PAK/89/2011 ...A.A... ...C... ...C... Asia-1/AFG/48/2011 ...A.A... ...C... ...C... Asia-1/AFG/51/2011 ...A.A... ...C... ...C... Asia-1/AFG/55/2011 ...A.A... ...C... ...C... Asia-1/BAR/3/2011 ...A.A... ..T..C... ...T..C... Asia-1/BAR/4/2011 ...A.A... ..T..C... ...T..C... Asia-1/IRN/33/2011 ...A.A... ..T..C... ...C... Asia-1/IRN/38/2011 ...A.A... ..T..C... ...C... Asia-1/IRN/43/2011 ...A.A... ..T..C... ...C... Asia-1/IRN/46/2011 ...A.A... ..T..C... ...C... Asia-1/PAK/90/2011 ...A.A... ..T..C... ...C... Asia-1/PAK/32/2011 ...A.A... ...C....A... ...C... Asia-1/PAK/109/2010 ...A.A... ...C....A... ...C...
3.2. Analyticalsensitivity/minimumdetectionlevelof
serotype-specificrRT-PCRprimers/probeassays
Fig. 2a–c shows the wide dynamic range of the single-plex assays using plasmid standards with the serotype O-, A-and Asia-1-specific primer/probe sets. Using DNA templates,
the three assays had a limit of detection of 1.78, 2.58 and 2.74 copies, respectively, thus demonstrating the high ana-lytical sensitivity of these tests. The amplification efficiencies for these three assays were estimated to be 94.9, 93.3 and 99.2%, for the serotype O, A and Asia-1 assays, respectively. Of the two formats, the singleplex assay format had a lower
Fig.2.AnalyticalsensitivityanddemonstrationofthedynamicrangeoftherRT-PCRassaysusingplasmidstandardswiththeserotypeO-(a),A-(b)andAsia-1-(c)specific primer/probesets.
minimum detection level than themultiplex version (data not shown).
4. Discussion
Whilepan-serotypicrRT-PCRassaysfordetectionofFMDVhave beenextensivelyevaluatedforroutineuse(Callahanetal.,2002; Shawetal.,2004;Moniwaetal.,2007),severalchallengesfacethe designofserotype-specificprimer/probesetsforrRT-PCR.Insilico analysescanbeusedtotrytoidentifyconserved sequencesfor primer/probebindingsitesthatallowthespecificrecognitionofall viruseswithinaparticularserotype,butdonotcross-reactwith virusesofotherserotypes.Thisprocessischallengingduetothe highvariabilityoftheFMDVgenomeandlackofsequencesthat areconservedwithin,butrestrictedto,aparticularserotype.For thesereasons,effortsherehaveconcentratedondetectingviruses ofparticularserotypesfromwithindistinctgeographicalregions orlineagesratherthanacrossallstrainsgloballywithinaserotype. ThiscurrentstudyutilisedVP1coding sequencestodesign and establishserotype-specificrRT-PCRassays;VP1isoneofthecapsid proteinswhichdisplaysepitope(s)onthevirussurfacetothehost’s immunesystem.VP1iswidelyacceptedasbeingthemost anti-genicallysignificantofthecapsidproteinsanditssequencecanbe usedtoidentifytheserotypeofthestrain.TheVP1codingsequence hasbeenthemostcommonlysequencedandhenceitisnowthe mostinformativeregionoftheFMDVgenomefordeterminingthe relationshipbetweendifferentstrainsforepidemiologicalanalyses. Initial screening of clinical samples in three different lab-oratories using singleplex assay formats showed that the serotype-specificprimer/probessets appropriately detectedthe FMDVgenomeofserotypeOPanAsia-2,serotypeAIran-05 and Asia-1strainsofsubgroups1,2and6asintended(Table3and sup-plementarydata—AnnexA).Furthermore,theassaysdiscriminated betweenvirusesbelongingtotheselineagesfromvirusesofother lineagesorsubgroupswithinserotypesO,AandAsia1,e.g.from otherregionsoftheworld.Nocross-reactivitywasdemonstrated intheassayswithheterotypicserotypesofFMDV.Equally impres-siveassayspecificitywasdemonstratedwhentheprimer/probe setswereusedinamultiplexassayformat(Table3,supplementary data—AnnexBandFig.1).FiveserotypeAsia-1virusesbelonging totheSindh-08lineagewerenotdetectedwiththemultiplex for-mat.Sequencingoftwooftheseisolatesshowedthatthiswasdue tothepositioningoftwomismatchesintheprobe-bindingregion (Table 4). Using either assay format, the specific primer/probe setswerealsoabletoidentifytheserotypeofsamplesdesignated FMDV-GD,therebyprovidingimportantadditionalepidemiological
informationforthesesamplesintheabsenceofanyserotypingdata providedbythecombineduseofAg-ELISAandVI.
Theanalyticalsensitivityofthespecificprimer/probesetsas determinedbytestingserialdilutionsofRNAandplasmid stan-dards demonstrated the wide dynamic range of theassays. As withanyotherRNAviruswitha rapidlyevolvinggenome, con-tinuous monitoringof the primer and probe sequences of the serotype-specific sets against the corresponding sequences of newlycirculatingandemergingviruseswillbeessentialtoensure thattheassaysmaintainfitnessforpurpose.However,theresults fromthisstudyclearlydemonstratethepotentialofrRT-PCRfor routineandrobustdetectionanddiscriminationofFMDVisolates belongingtogeographicallydistinct lineagesand sub-groupsof serotypesO,AandAsia-1currentlycirculatingintheMiddleEast. Previously,alineage-specificrRT-PCRhasbeendevelopedfor useinNorthAfricancountriestospecificallydetectSAT2viruses thatemergedfromsub-SaharanAfricaduring2012andto differ-entiatethesevirusesfromendemicFMDvirusstrainsthatmight bepresentinthesecountries(Ahmedetal.,2012).Thesefindings supporttheuseofthisapproachtodevelopassaystodetectother topotypesofFMDVserotypesO,AandAsia-1,andalsoforother serotypes,especiallySAT2asvirusesofthisserotypehavemore sequence variation in theVP1 coding sequence compared with virusesofserotypesO,AandC.Thiscurrentstudyisthefirstto describetheuseofmultiplelineage-specificrRT-PCRsforthe detec-tionanddiscriminationofFMDVin clinicalsamplesinendemic settings.Theseassaysrepresentthefirststeptowardsthe develop-mentofasuiteofmoleculartools(moleculartoolbox)fordifferent countriesandregions.Asimilarapproachcouldthereforebeused todevelopFMDV-serotypingassaysforothergeographicalregions oftheworld.
Acknowledgements
TheauthorsthankDr.NigelFerrisandGeoffreyHutchingsofthe WRLFMD,fortheinitialpropagation,characterisationandsupplyof thevirusesusedinthestudy.TheworkperformedatThePirbright InstitutewasfundedbyDefra,UK(Projectnumbers:SE1124and SE1127)whilefundingforDTUandCVLwasprovidedbyEuFMD.
AppendixA. Supplementarydata
Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j. jviromet.2014.07.002.
References
Ahmed,H.A.,Salem,S.A.,Habashi,A.R.,Arafa,A.A.,Aggour,M.G.,Salem,G.H.,Gaber, A.S.,Selem,O.,Abdelkader,S.H.,Knowles,N.J.,Madi,M.,Valdazo-González,B., Wadsworth,J.,Hutchings,G.H.,Mioulet,V.,Hammond,J.M.,King,D.P.,2012.
Emergenceoffoot-and-mouthdiseasevirusSAT2inEgyptduring2012. Trans-bound.Emerg.Dis.59,476–481.
Alexandersen, S., Forsyth, M.A., Reid, S.M., Belsham, G.J., 2000. Develop-mentofreversetranscription-PCR(oligonucleotideprobing)enzyme-linked immunosorbentassaysfordiagnosisandpreliminarytypingoffoot-and-mouth disease:anewsystemusingsimpleandaqueous-phasehybridization.J.Clin. Microbiol.38,4604–4613.
Belsham,G.J.,2005.TranslationandreplicationofFMDVRNA:‘Foot-and-mouth disease virus’.In:Mahy, B.W.J. (Ed.),Current Topics in Microbiologyand Immunology,vol.288.Springer,pp.43–70.
Callahan,J.D.,Brown,F.,Osorio,F.A.,Sur,J.H.,Kramer,E.,Long,G.W.,Lubroth,J., Ellis,S.J.,Shoulars,K.S.,Gaffney,K.L.,Rock,D.L.,Nelson,W.M.,2002.Useofa portablereal-timereversetranscriptase-polymerasechainreactionassayfor rapiddetectionoffoot-and-mouthdiseasevirus.J.Am.Vet.Med.Assoc.220, 1636–1642.
Callens,M.,DeClercq,K.,1997.Differentiationofthesevenserotypesof foot-and-mouthdiseasevirusbyreversetranscriptasepolymerasechainreaction.J.Virol. Methods67,35–44.
Ferris,N.P.,Dawson,M.,1988.Routineapplicationofenzyme-linked immunosor-bentassayin comparison with complementfixation for the diagnosisof foot-and-mouthandswinevesiculardiseases.Vet.Microbiol.16,201–209.
Ferris,N.P.,King,D.P.,Reid,S.M.,Shaw,A.E.,Hutchings,G.H.,2006.Comparisons oforiginallaboratoryresultsandretrospectiveanalysisbyreal-timereverse transcriptase-PCRofvirologicalsamplescollectedfromconfirmedcasesof foot-and-mouthdiseaseintheUKin2001.Vet.Rec.159,373–378.
Giridharan,P.,Hemadri,D.,Tosh,C.,Sanyal,A.,Bandyopadhyay,S.K.,2005. Develop-mentandevaluationofamultiplexPCRfordifferentiationoffoot-and-mouth diseasevirusstrainsnativetoIndia.J.Virol.Methods126,1–11.
King,D.P.,Ferris,N.P.,Shaw,A.E.,Reid,S.M.,Hutchings,G.H.,Giuffre,A.C.,Robida, J.M.,Callahan,J.D.,Nelson,W.M.,Beckham,T.R.,2006.Detectionof foot-and-mouthvirus:comparativediagnosticsensitivityoftwoindependentreal-time reversetranscription-polymerasechainreactionassays.J.Vet.Diagn.Invest.18, 93–97.
Knowles,N.J.,Samuel,A.R.,2003.Molecularepidemiologyoffoot-and-mouth dis-easevirus.VirusRes.91,65–80.
Madhanmohan, M., Nagendrakumar, S.B., Manikumar, K., Yuvaraj, S., Parida, S., Srinivasan, V.A., 2013. Development and evaluation of a real-time reverse transcription-loop-mediated isothermal amplification assay for rapid serotyping of foot-and-mouth disease virus. J. Virol.Methods 187, 195–202.
Moniwa,M.,Clavijo,A.,Li,M.,Collignon,B.,Kitching,P.R.,2007.Performanceofa foot-and-mouthdiseasevirusreversetranscription-polymerasechainreaction withamplificationcontrolsbetweenthreereal-timeinstruments.J.Vet.Diagn. Invest.19,9–20.
Reid,S.M.,Ferris,N.P.,Hutchings,G.H.,DeClercq,K.,Newman,B.J.,Knowles,N.J., Samuel,A.R.,2001.Diagnosisoffoot-and-mouthdiseasebyRT-PCR:useof phy-logeneticdatatoevaluateprimersforthetypingofviralRNAinclinicalsamples. Arch.Virol.146,2421–2434.
Reid,S.M.,Ferris,N.P.,Hutchings,G.H.,Zhang,Z.,Belsham,G.J.,Alexandersen,S., 2002.Detectionofallsevenserotypesoffoot-and-mouthdiseasevirusby real-time,fluorogenicreversetranscriptionpolymerasechainreactionassay.J.Virol. Methods105,67–80.
Reid,S.M.,Hutchings,G.H.,Ferris,N.P.,DeClercq,K.,1999.Diagnosisof foot-and-mouthdiseasebyRT-PCR:evaluationofprimersforserotypiccharacterisation ofviralRNAinclinicalsamples.J.Virol.Methods83,113–123.
Reid,S.M.,Ebert,K.,Bachanek-Bankowska,K.,Batten,C.,Sanders,A.,Wright,C., Shaw,A.E.,Ryan,E.D.,Hutchings,G.H.,Ferris,N.P.,Paton,D.J.,King,D.P.,2009.
Performanceofreal-timeRT-PCRforthedetectionoffoot-and-mouthdisease virusduringfieldoutbreaksintheUnitedKingdomin2007.J.Vet.Diag.Investig. 21(3),321–330.
Shaw, A.E.,Reid,S.M.,Ebert,K., Hutchings,G.H.,Ferris, N.P.,King,D.P.,2007.
Implementationofaone-stepreal-timeRT-PCRprotocolfordiagnosisof foot-and-mouthdisease.J.Virol.Methods143,81–85.
Shaw,A.E.,Reid,S.M.,King,D.P.,Hutchings,G.H.,Ferris,N.P.,2004.Enhanced labora-torydiagnosisoffootandmouthdiseasebyreal-timepolymerasechainreaction. Rev.Sci.Technol.23,1003–1009.
Suryanarayana, V., Madanamohan, B., Bist, P., Natarajan, C., Tratschin, J.D., 1999. Serotyping of foot-and-mouth disease virus by antigen capture reverse transcriptase/polymerase chain reaction. J. Virol. Methods 80, 45–52.
Vangrysperre,W.,DeClercq,K.,1996.Rapidandsensitivepolymerasechainreaction baseddetectionandtypingoffoot-and-mouthdiseasevirusinclinical sam-plesandcellcultureisolates,combinedwithasimultaneousdifferentiation withothergenomicallyand/orsymptomaticallyrelatedviruses.Arch.Virol.141, 331–344.